RMD Related Earnings News
-
Goldman Sachs Upgrades ResMed (RMD) to Conviction Buy
-
ResMed, Inc. (RMD) Tops Q3 EPS by 2c
-
ResMed, Inc. (RMD) Tops Q2 EPS by 2c
-
Canaccord Genuity Maintains Hold, Raises PT on ResMed (RMD)
-
Canaccord Genuity Raising PT and Estimates on ResMed (RMD); Solid Q4
-
ResMed, Inc. (RMD) Tops Q4 EPS by 4c
-
Canaccord Genuity Maintains a 'Hold' on ResMed (RMD); Raising PT on Solid Q3
-
Jefferies Lifts Price Target Revises Estimates on ResMed Inc. (RMD)
-
ResMed, Inc. (RMD) Tops Q3 EPS by 3c
-
ResMed, Inc. (RMD) Misses Q3 EPS by 2c
-
ResMed, Inc. (RMD) Tops Q4 EPS by 1c, Sales Top Expectations
-
ResMed (RMD) Reports In-Line Q1 EPS
-
ResMed (RMD) Tops Q2 EPS by 1c
-
ResMed (RMD) Posts Q1 EPS of $0.36, Tops by 4c
-
ResMed (RMD) Posts Q4 EPS of $0.68, Tops by 2c; Announces Two-For-One Stock Split
-
ResMed (RMD) Posts Q3 EPS of $0.63, Beats Views
-
ResMed (RMD) Tops Q2 EPS by 5c
-
ResMed (RMD) Tops Q3 Views
-
ResMed (RMD) Tops Q2 Views
-
ResMed (RMD) Tops Q4 View By 5c
-
ResMed (RMD) Reports Q1 EPS of $0.52, Beats by 6c
-
ResMed (RMD) Tops Q4 View By 2c
-
ResMed (RMD) Misses Q3 View By 2c
-
ResMed (RMD) Reports Mixed Q1 Earnings
-
ResMed (RMD) Reports Q4 EPS of $0.41
-
ResMed (RMD) Misses Q3 EPS by 3c; Announces Voluntary Recall
-
ResMed (RMD) Reports Q2 Earnings
-
ResMed (RMD) Reports In-Line Q1
-
ResMed (RMD) Tops Q4 EPS by 4c
-
EARNINGS DUE AFTER THE CLOSE TODAY AND BEFORE THE OPEN TOMORROW
-
ResMed (RMD) Reports Q3 EPS of $0.39
-
RMD Tops Q2 EPS by 5c
-
RMD In-line with Q3 EPS
-
RMD Q2 EPS 4 cents better than estimates
Back to RMD Stock Lookup
